InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,526.31
(
-0.05%
)
US TECH 100
18,468.40
(
-0.02%
)
Dow Jones
40,953.04
(
0.04%
)
Brent Oil
73.11
(
-0.69%
)
Bitcoin
58,232.33
(
1.42%
)
Post# of 4978075
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lucky__stock

Send PM Follow Ignore
Followers 0
Posts 7710
Boards Moderated 0
Alias Born 05/05/2020

lucky__stock

Re: None

Wednesday, 01/19/2022 11:35:32 AM

Wednesday, January 19, 2022 11:35:32 AM

Post# of 4978075
$QNTA #BreakingNews ! Medolife Rx, Inc. ("Medolife") (OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of QNTA product, Escozine, as a COVID-19 treatment. https://finance.yahoo.com/news/medolife-rx-submits-final-clinical-130000052.html

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up